Emerging resistance to antibiotics against respiratory bacteria: Impact on therapy of community-acquired pneumonia in children

Drug Resistance Updates

Volumn 5, Issue 2, 2002, Pages 73-87

  Esposito, Susanna ^a   Principi, Nicola ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Antimicrobial therapy; Children; Community acquired pneumonia; Resistance; Respiratory bacteria

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; CLINAFLOXACIN; ERYTHROMYCIN; GATIFLOXACIN; GENTAMICIN; GLYCYLCYCLINE DERIVATIVE; KETOLIDE; MACROLIDE; MOXIFLOXACIN; OXAZOLIDINONE DERIVATIVE; PENICILLIN DERIVATIVE; PROTEIN SYNTHESIS INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOGRAMIN DERIVATIVE; ANTIINFECTIVE AGENT;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; BACTERIUM; CHILD; COMMUNITY ACQUIRED PNEUMONIA; DRUG CHOICE; DRUG INDICATION; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; MICROBIOLOGICAL EXAMINATION; OUTCOMES RESEARCH; PATHOGENESIS; PENICILLIN RESISTANCE; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY SYSTEM; REVIEW; RISK FACTOR; STREPTOCOCCUS PNEUMONIAE; ANIMAL; BACTERIAL PNEUMONIA; COMMUNICABLE DISEASE; MICROBIOLOGY; MULTIDRUG RESISTANCE; PHYSIOLOGY; RESPIRATORY TRACT INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; CHILD; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; PNEUMONIA, BACTERIAL; RESPIRATORY TRACT INFECTIONS;

EID: 0036527637     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-7646(02)00018-3     Document Type: Review

References (99)

1. Therapy for children with invasive pneumococcal infections
2. Pneumococcal macrolide resistance: Myth or reality?
3. Overview of recent developments in carbapenem and trinem antibiotics
4. High serum procalcitonin concentrations in patients with sepsis and infection
5. Occult pneumonias: Empiric chest radiographs in febrile children with leukocytosis
6. Causes of childhood deaths in Bangladesh: Results of a nationwide verbal autopsy study
7. Telithromycin
8. Streptococcus pneumoniae in community-acquired pneumonia? How important is drug resistance?
9. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
10. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric communityacquired pneumonia: Comparative efficacy and safety of clarithromycin versus erythromycin ethylsuccinate
11. Expanded activity and utility of the new fluoroquinolones: A review
12. Community-acquired pneumonia
13. Break-through bacteremia and meningitis during treatment parenterally with cephalosporins for pneumococcal pneumonia
14. Advances in the research and development of chemotherapeutic agents for respiratory tract bacterial infections
15. Novel oral cephalosporins
16. Clinical outcome of invasive infections by penicillin-resistant Streptococcus pneumoniae in Korean children
17. Accuracy of radiographic differentiation of bacterial from non-bacterial pneumonia
18. Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men
19. Reliability of the chest radiograph in the diagnosis of lower respiratory infections in young children
20. Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae
21. Oxazolidinone antibiotics
22. Pneumococcus resistant to eryhthromycin and lincomycin
23. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of β-lactamase-positive strains resistant to amoxicillin-clavulanate: Results of a national multicenter surveillance study
24. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 Results from the SENTRY Antimicrobial Surveillance Program
25. Antimicrobial resistance with Streptococcus pneumoniae in the United States 1997-1998
26. Characteristics of Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia
27. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance 1995-1997
28. The Alexander Project 1996-1997: Latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections
29. The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in respiratory infection
30. Community-acquired pneumonia: New guidelines for management
31. Community-acquired pneumonia: The evolving challenge
32. Etiology of acute lower respiratory tract infections in Gambian children. I. Acute lower respiratory tract infections in infants presenting at the hospital
33. Increase in community-acquired methicillin-resistant Staphylococcus aureus in children
34. Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease
35. Failure of macrolide therapy in patients with bacteremia due to macrolide-resistant Streptococcus pneumoniae
36. The clinical impact of macrolide resistance in pneumococcal respiratory infections
37. Resistance of bacteria to erythromycin
38. Peptide antibiotics
39. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children
40. The contribution of specific pneumococcal serogroups to different disease manifestations: Implications for conjugate vaccine formulation and use. Part II
41. Management of community-acquired pneumonia in the era of pneumococcal resistance
42. Management of community-acquired pneumonia in the era of pneumococcal resistance: A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group
43. Etiology of childhood pneumonia: Serologic results of a prospective, population-based study
44. Extremely high incidence of macrolide and trimethoprimsulfamethoxazole resistance among clinical isolates of Streptococcus pneumoniae in Taiwan
45. Macrolide resistance among invasive Streptococcus pneumoniae isolates
46. Breakthrough sepsis in macrolide-resistant pneumococcal infection
47. A practical guide for the diagnosis and treatment of pediatric pneumonia
48. GAR-936
49. Incidence of communityacquired pneumonia in the population of four municipalities in eastern Finland
50. Etiology of community-acquired pneumonia in 254 hospitalized children
51. Drug-resistant Streptococcus pneumoniae infections: Clinical importance, drug treatment and prevention
52. Epidemiology, control and treatment of multiresistant pneumococci
53. Serum procalcitonin in pneumococcal pneumonia in children
54. Comparison of radiological findings and microbial aetiology of childhood pneumonia
55. White blood cell and differential counts in acute respiratory viral and bacterial infections in children
56. White blood cells, C-reactive protein and erythrocyte sedimentation rate in pneumococcal pneumonia in children
57. What's new in the antibiotic pipeline
58. Beta-lactamases in laboratory and clinical resistance
59. Resistance patterns of lower respiratory tract pathogens in Europe
60. Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy
61. Antibiotic susceptibility patterns and serotypes of antibiotic-resistant and invasive Streptococcus pneumoniae strains circulating in Italy
62. Prevalence of antimicrobial resistance in Streptococcus pneumoniae circulating in Italy: Results of the Italian Epidemiological Observatory Survey (1997-1999)
63. Community-acquired pneumonia
64. Diagnosis and management of pneumonia in children
65. Etiology and treatment of pneumonia
66. Community-acquired pneumonia in children
67. Value of the polymerase chain reaction assay in non-invasive respiratory samples for diagnosis of community-acquired pneumonia
68. Epidemiological aspects of antibiotic resistance in respiratory pathogens
69. Antibiotic resistance: Lessons for the future
70. Procalcitonin in children admitted to hospital with community-acquired pneumonia
71. Identification of a structural determinant for resistance to beta-lactam antibiotics in gram-positive bacteria
72. Magnitude of the problem of childhood pneumonia
73. Pneumonia: An 11-year study in a pediatric practice
74. Emergence of macrolide resistance during treatment of pneumococcal pneumonia
75. Comparison of the in vitro activity of ABT-773: A novel antibacterial ketolide, with erythromycin and ciprofloxacin against respiratory pathogens
76. Erythrocyte sedimentation rate, white blood cell count and serum C-reactive protein in assessing etiologic diagnosis of acute lower respiratory tract infections in children
77. Treatment of pneumococcal pneumonia
78. Pneumococcal macrolide resistance not a myth
79. Differential diagnosis of viral, mycoplasmal and bactaeremic pneumococcal pneumonias on admission to hospital
80. Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory tract infections
81. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections
82. Use of bacterial antigen detection in the diagnosis of pediatric lower respiratory tract infections
83. Pneumococcal meningitis during therapy of otitis media with clarithromycin
84. Childhood community-acquired pneumonia
85. The evolving threat of antibiotic resistance in Europe: New data from the Alexander Project
86. The epidemiology of acute respiratory tract infection in young children: Comparison of findings from several developing countries
87. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland
88. Prevalence of ermAM and mefE in penicillin-resistant Streptococcus pneumoniae
89. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-non- susceptible Streptococcus pneumoniae
90. Laboratory diagnosis of respiratory infections
91. Antimicrobial resistance in respiratory tract pathogens: Results of an international surveillance study
92. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States 1997-1998
93. Pneumonia in pediatric outpatients: Cause and clinical manifestations
94. Association of aminoacid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae
95. Clinical management of acute respiratory infections in children: A WHO memorandum
96. Etiology and treatment of community-acquired pneumonia in children
97. Biochemical characterisation of penicillin-resistant and sensitive penicillin binding protein 2x transpeptidase activities of Streptococcus pneumoniae and mechanistic implications in bacterial resistance to beta-lactam antibiotics